# A Study of LY3478045 in Healthy Participants

> **NCT04270370** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 72 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3478045
- **DRUG:** Placebo
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT04270370
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-16
- **Primary completion:** 2021-06-23
- **Final completion:** 2021-06-23
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2024-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04270370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04270370, "A Study of LY3478045 in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04270370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*